Asymmetry Capital Management, L.P. Buys Medtronic PLC, Sage Therapeutics Inc, DICE Therapeutics Inc, Sells Centene Corp, Sotera Health Co, Jazz Pharmaceuticals PLC

• New Purchases: MDT, SAGE, DICE, CYTK, QTRX, PTCT, BLU, ISEE, BAX, KURA, RNA, HZNP, AVTX, GMTX, BLSA, LRMR,
• Added Positions: HOLX, FOLD, PODD, ALKS, AVDL, ARNA,
• Reduced Positions: AZN, MRTX, KYMR, ACRS, ITOS, RGLS,
• Sold Out: CNC, SHC, JAZZ, ADPT, EPIX, MREO, BDSX, ASLN, GH, ARGX, FBRX, BIO, MCRB, GLTO,

For the details of Asymmetry Capital Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/asymmetry+capital+management%2C+l.p./current-portfolio/portfolio

1. Alkermes PLC (ALKS) - 373,382 shares, 6.92% of the total portfolio. Shares added by 22.32%
2. Medtronic PLC (MDT) - 83,737 shares, 6.31% of the total portfolio. New Position
3. Insulet Corp (PODD) - 36,732 shares, 6.28% of the total portfolio. Shares added by 26.91%
4. Hologic Inc (HOLX) - 138,884 shares, 6.16% of the total portfolio. Shares added by 200.72%
5. Sage Therapeutics Inc (SAGE) - 229,117 shares, 6.10% of the total portfolio. New Position

Asymmetry Capital Management, L.P. initiated holding in Medtronic PLC. The purchase prices were between $122.75 and $135.17, with an estimated average price of $129.47. The stock is now traded at around $120.173000. The impact to a portfolio due to this purchase was 6.31%. The holding were 83,737 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. initiated holding in Sage Therapeutics Inc. The purchase prices were between $40.26 and $57.37, with an estimated average price of $46.02. The stock is now traded at around $47.070000. The impact to a portfolio due to this purchase was 6.1%. The holding were 229,117 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. initiated holding in DICE Therapeutics Inc. The purchase prices were between $31.92 and $37, with an estimated average price of $34.06. The stock is now traded at around $34.009800. The impact to a portfolio due to this purchase was 5.42%. The holding were 275,165 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. initiated holding in Cytokinetics Inc. The purchase prices were between $18.54 and $35.74, with an estimated average price of $29.35. The stock is now traded at around $38.470000. The impact to a portfolio due to this purchase was 5.29%. The holding were 246,336 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. initiated holding in Quanterix Corp. The purchase prices were between $45.91 and $59.67, with an estimated average price of $51.65. The stock is now traded at around $56.110000. The impact to a portfolio due to this purchase was 4.85%. The holding were 161,933 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. initiated holding in PTC Therapeutics Inc. The purchase prices were between $37.01 and $44.74, with an estimated average price of $41.15. The stock is now traded at around $41.710000. The impact to a portfolio due to this purchase was 4.83%. The holding were 215,985 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. added to a holding in Hologic Inc by 200.72%. The purchase prices were between $67.56 and $80.74, with an estimated average price of $74.96. The stock is now traded at around $71.610000. The impact to a portfolio due to this purchase was 4.11%. The holding were 138,884 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. added to a holding in Amicus Therapeutics Inc by 118.51%. The purchase prices were between $8.74 and $11.84, with an estimated average price of $10.24. The stock is now traded at around $12.410000. The impact to a portfolio due to this purchase was 2.03%. The holding were 653,976 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. added to a holding in Insulet Corp by 26.91%. The purchase prices were between $260.36 and $307.27, with an estimated average price of $285.43. The stock is now traded at around $300.729300. The impact to a portfolio due to this purchase was 1.33%. The holding were 36,732 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. added to a holding in Alkermes PLC by 22.32%. The purchase prices were between $23.37 and $32.13, with an estimated average price of $28.23. The stock is now traded at around $30.550000. The impact to a portfolio due to this purchase was 1.26%. The holding were 373,382 shares as of 2021-09-30.

Asymmetry Capital Management, L.P. sold out a holding in Centene Corp. The sale prices were between $59.73 and $74.7, with an estimated average price of $66.89.

Asymmetry Capital Management, L.P. sold out a holding in Sotera Health Co. The sale prices were between $22.25 and $26.52, with an estimated average price of $24.22.

Asymmetry Capital Management, L.P. sold out a holding in Jazz Pharmaceuticals PLC. The sale prices were between $128.64 and $184.79, with an estimated average price of $151.34.

Asymmetry Capital Management, L.P. sold out a holding in Adaptive Biotechnologies Corp. The sale prices were between $30.02 and $39.87, with an estimated average price of $36.27.

Asymmetry Capital Management, L.P. sold out a holding in ESSA Pharma Inc. The sale prices were between $7.76 and $29.37, with an estimated average price of $15.99.

Asymmetry Capital Management, L.P. sold out a holding in Mereo BioPharma Group PLC. The sale prices were between $2.2 and $3.17, with an estimated average price of $2.66.